Exact(2)
Patients with undiscovered metastatic disease at diagnosis would therefore have displayed recurrence at the initial post-treatment screening, thus contributing to the first peak.
Of the 7 patients with CR, 2 displayed recurrence 6 months after the first HDICI, and 5 sustained CR with disease-free survival (DFS) ranging from 4.5 to 11.5 months (median, 7.2 months).
Similar(58)
A large number of fusions display recurrence of a fusion gene in combination with multiple different partners; for example, BRAF/ RAF1 [ 76, 79, 82, 83] and FGFR1/ 2/ 3 [ 88– 94] are fused to several different 5′ partners across different tissue types (Additional file 1).
In contrast, only 10% of mice displayed tumour recurrence in the trastuzumab plus LY 411 575 GSI group, and 0% of mice displayed tumour recurrence in the trastuzumab plus MRK-003 group.
Both PDT drugs displayed low recurrence rates, in favour of BF-200 ALA over MAL.
18 (69.2 %) of 26 patients in high TIF CD68 group displayed tumor recurrence (ρ = 0.015).
In both studies, ∼40% of mice previously treated with trastuzumab alone displayed tumour recurrence at 40 weeks.
For most subgroups, patients illuminated with narrowband LED lamps displayed lower recurrence rates than those illuminated with broadband lamps.
Remarkably, the CSF kappa/lambda FLC ratio decreased from 3.6 to 1.6, while the serum kappa/lambda FLC ratio remained largely unchanged at a value of 1.63 (data not shown), and subsequent imaging of the brain displayed a recurrence of the former lesions.
The Adjuvant! model forecasted a broad range of local therapy recurrence and mortality estimates, displayed by increasing recurrence risk in the second column of Table 1.
All patients in the prior EHPM group underwent curative resection and did not display any recurrence of the malignancy.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com